Smart bomb virus shows promise as brain tumor immunotherapy – Science Daily
|
Smart bomb virus shows promise as brain tumor immunotherapy
Science Daily Smart bomb virus shows promise as brain tumor immunotherapy. In clinical trial, 20 percent of patients with recurrent glioblastoma live 3-plus years. Date: February 12, 2018; Source: University of Texas M. D. Anderson Cancer Center; Summary: A common … |
